Eli Lilly to buy Sigilon Therapeutics to expand diabetes treatments
Former J&J sales rep indicted on charges of defrauding Boston hospital
FDA blesses CellTrans' Lantidra, the first cell therapy for Type 1 diabetes
Sanofi says it's back to the drawing board on mRNA flu vaccines
*please scroll down for all the latest news*
